{"entity":{"type":"insider","cik":"0001339375","url":"/insider/0001339375","json_url":"/insider/0001339375.json","name":"Riley Antony A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2006-05-15","last":"2026-01-02","span_basis":"filed_date"},"name_variants":[{"name":"Riley Antony A","source":"filing","n_filings":5,"first_seen":"2018-05-24","last_seen":"2026-01-02"},{"name":"Riley Anthony A","source":"filing","n_filings":2,"first_seen":"2006-05-15","last_seen":"2006-10-04"}],"transactions":[{"id":6008271,"accession":"0001339375-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001339375-26-000002","line_url":"/filing/0001339375-26-000002#line-1","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9680.0,"shares_display":"9,680","price_per_share":26.3257,"price_display":"26.33","price_state":"stated","total_value":254832.776,"total_display":"254,832.78","total_whole":"254,833","shares_owned_after":41520.0,"shares_owned_after_display":"41,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":2662891,"accession":"0001415889-24-027557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-027557","line_url":"/filing/0001415889-24-027557#line-1","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22514.0,"shares_display":"22,514","price_per_share":5.552,"price_display":"5.55","price_state":"stated","total_value":124997.728,"total_display":"124,997.73","total_whole":"124,998","shares_owned_after":30776.0,"shares_owned_after_display":"30,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-22","scope":"insider"},{"id":4760915,"accession":"0000899243-21-035246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-035246","line_url":"/filing/0000899243-21-035246","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.2442192,"price_display":"4.24","price_state":"stated","total_value":106105.48,"total_display":"106,105.48","total_whole":"106,105","shares_owned_after":14581.0,"shares_owned_after_display":"14,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-07","scope":"insider","n_lines":2},{"id":3239245,"accession":"0000899243-20-018041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-018041","line_url":"/filing/0000899243-20-018041#line-2","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":14.11,"price_display":"14.11","price_state":"stated","total_value":28220.0,"total_display":"28,220.00","total_whole":"28,220","shares_owned_after":36065.0,"shares_owned_after_display":"36,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-06-30","scope":"insider"},{"id":3239241,"accession":"0000899243-20-018041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018041","line_url":"/filing/0000899243-20-018041#line-1","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4700.0,"shares_display":"4,700","price_per_share":14.516,"price_display":"14.52","price_state":"stated","total_value":68225.2,"total_display":"68,225.20","total_whole":"68,225","shares_owned_after":34065.0,"shares_owned_after_display":"34,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":6259960,"accession":"0001209191-18-033088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-033088","line_url":"/filing/0001209191-18-033088#line-1","is_derivative":false,"issuer_cik":"0001339375","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001339375","owner_cik":"0001339375","owner_name":"Riley Antony A","owner_display_name":"Riley Antony A","owner_url":"/insider/0001339375","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":30100.0,"total_display":"30,100.00","total_whole":"30,100","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-24","scope":"insider"},{"id":4078933,"accession":"0001181431-06-056809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-056809","line_url":"/filing/0001181431-06-056809#line-1","is_derivative":false,"issuer_cik":"0001056794","issuer_name":"AVANEX CORP","issuer_ticker":"AVNX","issuer_name_source":null,"issuer_url":"/issuer/0001056794","owner_cik":"0001339375","owner_name":"Riley Anthony A","owner_display_name":"Riley Anthony A","owner_url":"/insider/0001339375","role":"Officer (V.P., Finance)","role_mark":"O","role_mark_label":"Officer (V.P., Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28261.0,"shares_display":"28,261","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":46630.65,"total_display":"46,630.65","total_whole":"46,631","shares_owned_after":31260.0,"shares_owned_after_display":"31,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-02","filed_date":"2006-10-04","scope":"insider"},{"id":5540733,"accession":"0001181431-06-030409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-030409","line_url":"/filing/0001181431-06-030409#line-1","is_derivative":false,"issuer_cik":"0001056794","issuer_name":"AVANEX CORP","issuer_ticker":"AVNX","issuer_name_source":null,"issuer_url":"/issuer/0001056794","owner_cik":"0001339375","owner_name":"Riley Anthony A","owner_display_name":"Riley Anthony A","owner_url":"/insider/0001339375","role":"Officer (V.P., Finance)","role_mark":"O","role_mark_label":"Officer (V.P., Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16208.0,"shares_display":"16,208","price_per_share":1.99,"price_display":"1.99","price_state":"stated","total_value":32253.92,"total_display":"32,253.92","total_whole":"32,254","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-11","filed_date":"2006-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419041","name":"Forte Biosciences, Inc.","url":"/issuer/0001419041","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":4,"first_seen":"2020-06-30","last_seen":"2026-01-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001711279","name":"Krystal Biotech, Inc.","url":"/issuer/0001711279","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2018-05-24","last_seen":"2018-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001056794","name":"AVANEX CORP","url":"/issuer/0001056794","role":"Officer (V.P., Finance)","n_filings":2,"first_seen":"2006-05-15","last_seen":"2006-10-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001339375","retrieved_at":"2026-08-22T22:25:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}